Dr. John Kelton joins HRI Board of Directors

Share this:

We are pleased to welcome Dr. John Kelton, a distinguished University Professor and award-winning hematologist to our Board of Directors

HRI is pleased to welcome Dr. John Kelton to our Board of Directors.

Dr. Kelton is a Distinguished University Professor and Executive Director of the Michael G. DeGroote Initiative for Innovation in Healthcare at McMaster University in Hamilton. He assumed his current role in 2016, after completing a 15-year term as McMaster’s Dean of the Faculty of Health Sciences and Vice-President for Health Sciences. He also served concurrently as Dean of McMaster’s Michael G. DeGroote School of Medicine.

During Dr. Kelton’s tenure, McMaster earned recognition as one of the top 40 universities in the world in medicine and health sciences.

Dr. Kelton is a practicing hematologist at Hamilton Health Sciences. He leads an internationally recognized research program exploring platelet and bleeding disorders. He has also earned global attention for his research on bleeding disorders of pregnant women and heparin-induced thrombocytopenia.

In 2015, Dr. Kelton was named a member of the Order of Canada. He has been awarded an honourary Doctorate of Science from the University of Waterloo, an honourary Doctorate of Law from the University of Windsor, and an honourary Doctorate of Science from Western University. He is also the recipient of a Prix Galien Research Award.

Dr. Kelton brings a wealth of experience to the HRI Board of Directors. His expertise in clinical research and innovation will be an asset as HRI continues to accelerate Canadian progress in clinical treatment and outcomes for mental illness and addiction.